bibliographicCitation |
Thursky KA, Worth LJ, Seymour JF, Miles Prince H, Slavin MA. Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab*. Br J Haematol. 2006 Jan;132(1):3–12. doi: 10.1111/j.1365-2141.2005.05789.x. PMID: 16371014. |